Medicinova Inc Common Stock (MNOV)

About MNOV

MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It develops MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent in Phase 2 clinical trial for treating neurological and other disorders, such as progressive multiple sclerosis, amyotrophic lateral sclerosis,…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

6

Website

medicinova.com/

Fundamentals

1-day range

$1.42$1.45

Market cap

$65.46M

P/E (trailing)

—

P/E (forward)

-3.19

EPS (trailing)

$-0.24

Dividend yield

—

Beta

0.65

Avg. volume

49.6K

Forecasts

3 analyst ratings

Medicinova Inc Common Stock Competitors

Chosen by industry and closest market cap.

• MNOV

  Medicinova Inc Common Stock

  $1.44

  ▲ 1.05%
  Market cap $65.46MP/E —
  $1.17$1.96
• ELTX

  Elicio Therapeutics Inc. Common Stock

  $2.86

  ▼ 4.67%
  Market cap $65.84MP/E —
  $2.66$16
• CING

  Cingulate Inc. Common Stock

  $5.32

  ▼ 2.21%
  Market cap $65.06MP/E —
  $3.16$11.89
• PLRX

  Pliant Therapeutics Inc. Common Stock

  $1.11

  ▼ 3.48%
  Market cap $64.40MP/E —
  $1.02$1.95
• SPRO

  Spero Therapeutics Inc. Common Stock

  $1.2

  ▼ 0.83%
  Market cap $66.59MP/E 4.73
  $1.08$3.08
• ACRV

  Acrivon Therapeutics Inc. Common Stock

  $2.06

  ▼ 4.19%
  Market cap $66.77MP/E —
  $1.27$3.56
• RNTX

  Rein Therapeutics Inc. Common Stock

  $0.7621

  ▼ 2.67%
  Market cap $63.77MP/E —
  $0.694$2.18

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• MediciNova (MNOV) Reports Q2 Loss, Tops Revenue Estimates
  Yahoo · 8/13/2026
• MaxCyte, Inc. (MXCT) Reports Q2 Loss, Beats Revenue Estimates
  Yahoo · 8/12/2026
• Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates
  Yahoo · 8/6/2026

• Hideki Nagao · June 23, 2026 · Grant

  44.5K
• Lemerond Nicole · June 23, 2026 · Grant

  44.5K
• BEAVER CAROLYN · June 23, 2026 · Grant

  44.5K

Institutional Ownership

March 31, 2026

Total shares held

5.09M

Total value held

$6.96M

Institutional holders

27